Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Canadian Sec - Free Realtime Quote CAD

Vext Science, Inc. (VEXT.CN)

Compare
0.1200
-0.0050
(-4.00%)
As of 9:55:34 AM EDT. Market Open.
Currency in CAD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
35,997.5810
35,997.5810
34,812.3110
35,410.6360
37,243.7090
Cost of Revenue
27,019.8360
27,019.8360
22,773.8850
12,312.1870
20,812.0030
Gross Profit
8,977.7450
8,977.7450
12,038.4260
23,098.4490
16,431.7060
Operating Expense
20,157.7440
20,157.7440
19,881.5510
13,815.1990
7,221.1400
Operating Income
-11,179.9990
-11,179.9990
-7,843.1250
9,283.2500
9,210.5660
Net Non Operating Interest Income Expense
-3,704.4720
-3,704.4720
-3,635.4090
-1,940.5600
-1,493.0420
Other Income Expense
-6,237.7120
-6,237.7120
14,841.2770
-644.7860
-897.4380
Pretax Income
-21,122.1830
-21,122.1830
3,362.7430
6,697.9040
6,820.0860
Tax Provision
1,312.9930
1,312.9930
-1,035.7040
-4,221.3760
1,833.3670
Net Income Common Stockholders
-22,435.1760
-22,435.1760
4,398.4470
10,919.2800
4,986.7190
Diluted NI Available to Com Stockholders
-22,435.1760
-22,435.1760
4,398.4470
10,919.2800
4,986.7190
Basic EPS
-0.08
--
0.03
0.08
0.04
Diluted EPS
-0.08
--
0.03
0.08
0.03
Basic Average Shares
240,912.9240
--
164,482.8270
138,853.5290
136,712.6240
Diluted Average Shares
240,912.9240
--
164,735.3350
139,534.6600
146,414.4010
Rent Expense Supplemental
--
--
--
--
446.2830
Total Expenses
47,177.5800
47,177.5800
42,655.4360
26,127.3860
28,033.1430
Net Income from Continuing & Discontinued Operation
-22,435.1760
-22,435.1760
4,398.4470
10,919.2800
4,986.7190
Normalized Income
-20,208.0696
-20,208.0696
-7,395.3263
11,060.3637
5,303.2335
Interest Income
220.2450
220.2450
176.2370
111.9920
739.4870
Interest Expense
3,924.7170
3,924.7170
3,811.6460
2,052.5520
2,232.5290
Net Interest Income
-3,704.4720
-3,704.4720
-3,635.4090
-1,940.5600
-1,493.0420
EBIT
-17,197.4660
-17,197.4660
7,174.3890
8,750.4560
9,052.6150
EBITDA
-2,020.5750
-2,020.5750
16,767.3550
15,184.9040
12,341.3980
Reconciled Cost of Revenue
20,578.8180
20,578.8180
19,221.9320
9,870.6170
18,558.2120
Reconciled Depreciation
15,176.8910
15,176.8910
9,592.9660
6,434.4480
3,288.7830
Net Income from Continuing Operation Net Minority Interest
-22,435.1760
-22,435.1760
4,398.4470
10,919.2800
4,986.7190
Total Unusual Items Excluding Goodwill
-2,819.1220
-2,819.1220
14,928.8270
-178.5870
-432.8810
Total Unusual Items
-2,819.1220
-2,819.1220
14,928.8270
-178.5870
-432.8810
Normalized EBITDA
798.5470
798.5470
1,838.5280
15,363.4910
12,774.2790
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0002
0.0003
Tax Effect of Unusual Items
-592.0156
-592.0156
3,135.0537
-37.5033
-116.3665
12/31/2021 - 5/13/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

VREO.CN Vireo Growth Inc.
0.5100
0.00%
 
AVCNF Avicanna Inc.
0.1850
0.00%
 
CBST.NE The Cannabist Company Holdings Inc.
0.0500
0.00%
 
ROMJ.V Rubicon Organics Inc.
0.4800
0.00%
 
TSND.TO TerrAscend Corp.
0.3600
0.00%
 
JUSH.CN Jushi Holdings Inc.
0.4200
0.00%
 
IAN.CN iAnthus Capital Holdings, Inc.
0.0100
0.00%
 
CXXI.CN C21 Investments Inc.
0.2250
0.00%
 
MDP.TO Medexus Pharmaceuticals Inc.
2.4500
+4.26%
 
IXHL Incannex Healthcare Inc.
0.5801
-7.78%